News
Medicare Part D Plans Increased Restrictions on Drug Coverage
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Research
All Research Featured Research
Journal Article
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011–20
March 4, 2024
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
Evidence Base
A Spoonful of Sugar Makes the Medicine Go Down
January 30, 2024
Featured Experts: Geoffrey Joyce, PhD
Perspective
How the Secrecy of Middlemen Inflates Drug Prices
October 14, 2023
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
Journal Article
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market
August 14, 2023
Featured Experts: Neeraj Sood, PhD
Perspective
Blame Capitalism? Why Hundreds of Decades-Old Yet Vital Drugs Are Nearly Impossible to Find
July 20, 2023
Featured Experts: Geoffrey Joyce, PhD
Testimony
Testimony on Pharmacy Benefit Managers and the Prescription Drug Supply Chain
March 30, 2023
Featured Experts: Karen Van Nuys, PhD
Perspective
Ending Health Insurance for Generic Drugs Would Save Patients Money
March 28, 2023
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
Evidence Base
Eli Lilly Is Cutting Insulin Prices and Capping Copays at $35 – 5 Questions Answered
March 3, 2023
Featured Experts: Dana Goldman, PhD, Karen Van Nuys, PhD
Testimony
Testimony on Bringing Transparency and Accountability to Pharmacy Benefit Managers
February 17, 2023
Featured Experts: Erin Trish, PhD
Perspective
Drugmakers Aren’t Driving Inflation. Price Controls Would Hinder Medical Progress
August 7, 2022
Featured Experts: Dana Goldman, PhD, Erin Trish, PhD
Perspective
The Cantwell-Grassley PBM Bill Is Much Needed But More Can Be Done
July 12, 2022
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
Perspective
PBMs Are Inflating the Cost of Generic Drugs. They Must Be Reined In
July 5, 2022
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
White Paper
U.S. Consumers Overpay for Generic Drugs
May 31, 2022
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
Comment Letter
Comments to the Federal Trade Commission on Pharmacy Benefit Managers
May 25, 2022
Featured Experts: Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Karen Mulligan, PhD, Neeraj Sood, PhD, Erin Trish, PhD, Karen Van Nuys, PhD
Perspective
Who Is Really Driving Up Insulin Costs?
April 18, 2022
Featured Experts: Karen Van Nuys, PhD, Erin Trish, PhD, Neeraj Sood, PhD
Journal Article
Pharmacy Switching in Response to Preferred Pharmacy Networks in Medicare Part D
March 17, 2022
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD